{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:40:17Z","timestamp":1786981217488,"version":"build-2736575974"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T00:00:00Z","timestamp":1673308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T00:00:00Z","timestamp":1673308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Chang-Gung Medical Research Progress","award":["CMRPG 3K2232"],"award-info":[{"award-number":["CMRPG 3K2232"]}]},{"name":"Chang-Gung Medical Research Progress","award":["CMRPG 3K0351"],"award-info":[{"award-number":["CMRPG 3K0351"]}]},{"name":"the National Science Council","award":["MOST110-2314-B-182A-033-"],"award-info":[{"award-number":["MOST110-2314-B-182A-033-"]}]},{"name":"the National Science Council","award":["NMRPG3K0361"],"award-info":[{"award-number":["NMRPG3K0361"]}]},{"name":"the National Science Council","award":["MOST111-2314-B-182A-110-"],"award-info":[{"award-number":["MOST111-2314-B-182A-110-"]}]},{"name":"the National Science Council","award":["NMRPG3M0321"],"award-info":[{"award-number":["NMRPG3M0321"]}]},{"DOI":"10.13039\/501100020433","name":"Taiwan Foundation for Rare Disorders","doi-asserted-by":"publisher","award":["TFRD"],"award-info":[{"award-number":["TFRD"]}],"id":[{"id":"10.13039\/501100020433","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020433","name":"Taiwan Foundation for Rare Disorders","doi-asserted-by":"publisher","award":["PMRPG3M0061"],"award-info":[{"award-number":["PMRPG3M0061"]}],"id":[{"id":"10.13039\/501100020433","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1007\/s10875-022-01423-1","type":"journal-article","created":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T23:28:45Z","timestamp":1673306925000},"page":"717-727","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Distinct Lymphocyte Immunophenotyping and Quantitative Anti-Interferon Gamma Autoantibodies in Taiwanese HIV-Negative Patients with Non-Tuberculous Mycobacterial Infections"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2683-3169","authenticated-orcid":false,"given":"Wen-I.","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-Fan","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Long","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huey-Ling","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Ying","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Ting","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Jou","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Chen","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6710-3432","authenticated-orcid":false,"given":"Ting-Shu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,10]]},"reference":[{"issue":"8","key":"1423_CR1","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1056\/NEJMoa1111160","volume":"367","author":"SK Browne","year":"2012","unstructured":"Browne SK, Burbelo PD, Chetchotisakd P, et al. Adult-onset immunodeficiency in Thailand and Taiwan. N Engl J Med. 2012;367(8):725\u201334. https:\/\/doi.org\/10.1056\/NEJMoa1111160.","journal-title":"N Engl J Med"},{"issue":"12","key":"1423_CR2","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/S1473-3099(10)70196-1","volume":"10","author":"SK Browne","year":"2010","unstructured":"Browne SK, Holland SM. Anticytokine autoantibodies in infectious diseases: pathogenesis and mechanisms. Lancet Infect Dis. 2010;10(12):875\u201385. https:\/\/doi.org\/10.1016\/S1473-3099(10)70196-1.","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"1423_CR3","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1182\/blood-2012-08-452482","volume":"121","author":"CY Chi","year":"2013","unstructured":"Chi CY, Chu CC, Liu JP, et al. Anti-IFN-\u03b3 autoantibodies in adults with disseminated nontuberculous mycobacterial infections are associated with HLA-DRB1*16:02 and HLA-DQB1*05:02 and the reactivation of latent varicella-zoster virus infection. Blood. 2013;121(8):1357\u201366. https:\/\/doi.org\/10.1182\/blood-2012-08-452482.","journal-title":"Blood"},{"key":"1423_CR4","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.coi.2021.05.007","volume":"72","author":"HP Shih","year":"2021","unstructured":"Shih HP, Ding JY, Yeh CF, Chi CY, Ku CL. Anti-interferon-\u03b3 autoantibody-associated immunodeficiency. Curr Opin Immunol. 2021;72:206\u201314. https:\/\/doi.org\/10.1016\/j.coi.2021.05.007.","journal-title":"Curr Opin Immunol"},{"issue":"10","key":"1423_CR5","doi-asserted-by":"publisher","first-page":"e0140473","DOI":"10.1371\/journal.pone.0140473","volume":"10","author":"CW Tseng","year":"2015","unstructured":"Tseng CW, Lai KL, Chen DY, Lin CH, Chen HH. The Incidence and Prevalence of Common Variable Immunodeficiency Disease in Taiwan, A Population-Based Study. Plos One. 2015;10(10):e0140473. https:\/\/doi.org\/10.1371\/journal.pone.0140473.","journal-title":"Plos One"},{"issue":"5","key":"1423_CR6","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/S1081-1206(10)60569-8","volume":"99","author":"WI Lee","year":"2007","unstructured":"Lee WI, Huang JL, Kuo ML, Lin SJ, Chen LC, Chen MT, Jaing TH. Analysis of genetic defects in patients with the common variable immunodeficiency phenotype in a single Taiwanese tertiary care hospital. Ann Allergy Asthma Immunol. 2007;99(5):433\u201342. https:\/\/doi.org\/10.1016\/S1081-1206(10)60569-8.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"1423_CR7","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.smim.2014.09.008","volume":"26","author":"J Bustamante","year":"2014","unstructured":"Bustamante J, Boisson-Dupuis S, Abel L, Casanova JL. Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-\u03b3 immunity. Semin Immunol. 2014;26(6):454\u201370. https:\/\/doi.org\/10.1016\/j.smim.2014.09.008.","journal-title":"Semin Immunol"},{"issue":"4","key":"1423_CR8","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/imcb.12210","volume":"97","author":"J Rosain","year":"2019","unstructured":"Rosain J, Kong XF, Martinez-Barricarte R, et al. Mendelian susceptibility to mycobacterial disease: 2014\u20132018 update. Immunol Cell Biol. 2019;97(4):360\u20137. https:\/\/doi.org\/10.1111\/imcb.12210.","journal-title":"Immunol Cell Biol"},{"issue":"6","key":"1423_CR9","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.smim.2006.07.010","volume":"18","author":"O Filipe-Santos","year":"2006","unstructured":"Filipe-Santos O, Bustamante J, Chapgier A, et al. Inborn errors of IL-12\/23- and IFN-gamma-mediated immunity: molecular, cellular, and clinical features. Semin Immunol. 2006;18(6):347\u201361. https:\/\/doi.org\/10.1016\/j.smim.2006.07.010.","journal-title":"Semin Immunol"},{"issue":"7","key":"1423_CR10","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1084\/jem.20060085","volume":"203","author":"O Filipe-Santos","year":"2006","unstructured":"Filipe-Santos O, Bustamante J, Haverkamp MH, et al. X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production. J Exp Med. 2006;203(7):1745\u201359. https:\/\/doi.org\/10.1084\/jem.20060085.","journal-title":"J Exp Med"},{"issue":"5528","key":"1423_CR11","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1126\/science.1061154","volume":"293","author":"S Dupuis","year":"2001","unstructured":"Dupuis S, Dargemont C, Fieschi C, et al. Impairment of mycobacterial but not viral immunity by a germline human STAT1 mutation. Science. 2001;293(5528):300\u20133. https:\/\/doi.org\/10.1126\/science.1061154.","journal-title":"Science"},{"issue":"3","key":"1423_CR12","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/ng1097","volume":"33","author":"S Dupuis","year":"2003","unstructured":"Dupuis S, Jouanguy E, Al-Hajjar S, et al. Impaired response to interferon-alpha\/beta and lethal viral disease in human STAT1 deficiency. Nat Genet. 2003;33(3):388\u201391. https:\/\/doi.org\/10.1038\/ng1097.","journal-title":"Nat Genet"},{"issue":"3","key":"1423_CR13","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/ni.1992","volume":"12","author":"J Bustamante","year":"2011","unstructured":"Bustamante J, Arias AA, Vogt G, et al. Germline CYBB mutations that selectively affect macrophages in kindreds with X-linked predisposition to tuberculous mycobacterial disease. Nat Immunol. 2011;12(3):213\u201321. https:\/\/doi.org\/10.1038\/ni.1992.","journal-title":"Nat Immunol"},{"issue":"2","key":"1423_CR14","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1056\/NEJMoa1100066","volume":"365","author":"S Hambleton","year":"2011","unstructured":"Hambleton S, Salem S, Bustamante J, et al. IRF8 mutations and human dendritic-cell immunodeficiency. N Engl J Med. 2011;365(2):127\u201338. https:\/\/doi.org\/10.1056\/NEJMoa1100066.","journal-title":"N Engl J Med"},{"issue":"5","key":"1423_CR15","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.imbio.2012.08.281","volume":"218","author":"WI Lee","year":"2013","unstructured":"Lee WI, Huang JL, Wu TS, et al. Patients with inhibitory and neutralizing auto-antibodies to interferon-\u03b3 resemble the sporadic adult-onset phenotype of Mendelian Susceptibility to Mycobacterial Disease (MSMD) lacking Bacille Calmette-Guerin (BCG)-induced diseases. Immunobiology. 2013;218(5):762\u201371. https:\/\/doi.org\/10.1016\/j.imbio.2012.08.281.","journal-title":"Immunobiology"},{"key":"1423_CR16","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.coi.2021.07.001","volume":"72","author":"S Boisson-Dupuis","year":"2021","unstructured":"Boisson-Dupuis S, Bustamante J. Mycobacterial diseases in patients with inborn errors of immunity. Curr Opin Immunol. 2021;72:262\u201371. https:\/\/doi.org\/10.1016\/j.coi.2021.07.001.","journal-title":"Curr Opin Immunol"},{"issue":"1","key":"1423_CR17","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s15010-010-0067-3","volume":"39","author":"T Kampitak","year":"2011","unstructured":"Kampitak T, Suwanpimolkul G, Browne S, Suankratay C. Anti-interferon-\u03b3 autoantibody and opportunistic infections: case series and review of the literature. Infection. 2011;39(1):65\u201371. https:\/\/doi.org\/10.1007\/s15010-010-0067-3.","journal-title":"Infection"},{"issue":"7","key":"1423_CR18","doi-asserted-by":"publisher","first-page":"4769","DOI":"10.4049\/jimmunol.175.7.4769","volume":"175","author":"SY Patel","year":"2005","unstructured":"Patel SY, Ding L, Brown MR, et al. Anti-IFN-gamma autoantibodies in disseminated nontuberculous mycobacterial infections. J Immunol. 2005;175(7):4769\u201376. https:\/\/doi.org\/10.4049\/jimmunol.175.7.4769.","journal-title":"J Immunol"},{"key":"1423_CR19","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.3389\/fimmu.2019.02833","volume":"10","author":"WI Lee","year":"2019","unstructured":"Lee WI, Fan WL, Lu CH, et al. A Novel CD3G Mutation in a Taiwanese Patient With Normal T Regulatory Function Presenting With the CVID Phenotype Free of Autoimmunity-Analysis of all Genotypes and Phenotypes. Front Immunol. 2019;10:2833. https:\/\/doi.org\/10.3389\/fimmu.2019.02833.","journal-title":"Front Immunol"},{"issue":"2","key":"1423_CR20","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s10875-008-9253-9","volume":"29","author":"WI Lee","year":"2009","unstructured":"Lee WI, Huang JL, Lin TY, et al. Chinese patients with defective IL-12\/23-interferon-gamma circuit in Taiwan: partial dominant interferon-gamma receptor 1 mutation presenting as cutaneous granuloma and IL-12 receptor beta1 mutation as pneumatocele. J Clin Immunol. 2009;29(2):238\u201345. https:\/\/doi.org\/10.1007\/s10875-008-9253-9.","journal-title":"J Clin Immunol"},{"issue":"6","key":"1423_CR21","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1007\/s10875-021-01055-x","volume":"41","author":"CY Wu","year":"2021","unstructured":"Wu CY, Chen YC, Lee WI, et al. Clinical Features of Female Taiwanese Carriers with X-linked Chronic Granulomatous Disease from 2004 to 2019. J Clin Immunol. 2021;41(6):1303\u201314. https:\/\/doi.org\/10.1007\/s10875-021-01055-x.","journal-title":"J Clin Immunol"},{"issue":"3","key":"1423_CR22","doi-asserted-by":"publisher","first-page":"e178","DOI":"10.1016\/S1473-3099(21)00586-7","volume":"7","author":"C Lange","year":"2022","unstructured":"Lange C, B\u00f6ttger EC, Cambau E, et al. expert panel group for management recommendations in non-tuberculous mycobacterial pulmonary diseases Consensus management recommendations for less common non-tuberculous mycobacterial pulmonary diseases. Lancet Infect Dis. 2022;7(3):e178\u201390.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"1423_CR23","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12967-020-02289-w","volume":"18","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Zhang Y, Han J, Yang M, Zhu J, Jin T. Transitional B cells involved in autoimmunity and their impact on neuroimmunological diseases. J Transl Med. 2020;18(1):131. https:\/\/doi.org\/10.1186\/s12967-020-02289-w.","journal-title":"J Transl Med"},{"issue":"32","key":"1423_CR24","doi-asserted-by":"publisher","first-page":"13451","DOI":"10.1073\/pnas.0901984106","volume":"106","author":"M Rakhmanov","year":"2009","unstructured":"Rakhmanov M, Keller B, Gutenberger S, et al. Circulating CD21low B cells in common variable immunodeficiency resemble tissue homing, innate-like B cells. Proc Natl Acad Sci U S A. 2009;106(32):13451\u20136. https:\/\/doi.org\/10.1073\/pnas.0901984106.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1423_CR25","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.3389\/fimmu.2019.02768","volume":"10","author":"PD Pioli","year":"2019","unstructured":"Pioli PD. Plasma Cells, the Next Generation: Beyond Antibody Secretion. Front Immunol. 2019;10:2768. https:\/\/doi.org\/10.3389\/fimmu.2019.02768.","journal-title":"Front Immunol"},{"key":"1423_CR26","doi-asserted-by":"publisher","first-page":"873644","DOI":"10.3389\/fimmu.2022.873644","volume":"13","author":"H Yan","year":"2022","unstructured":"Yan H, Li B, Su R, Gao C, Li X, Wang C. Preliminary Study on the Imbalance Between Th17 and Regulatory T Cells in Antiphospholipid Syndrome. Front Immunol. 2022;13:873644. https:\/\/doi.org\/10.3389\/fimmu.2022.873644.","journal-title":"Front Immunol"},{"key":"1423_CR27","doi-asserted-by":"publisher","first-page":"107563","DOI":"10.1016\/j.intimp.2021.107563","volume":"96","author":"Y Xia","year":"2021","unstructured":"Xia Y, Fang X, Dai X, et al. Iguratimod ameliorates nephritis by modulating the Th17\/Treg paradigm in pristane-induced lupus. Int Immunopharmacol. 2021;96:107563. https:\/\/doi.org\/10.1016\/j.intimp.2021.107563.","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"1423_CR28","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s12016-017-8608-5","volume":"53","author":"G Carvajal Alegria","year":"2017","unstructured":"Carvajal Alegria G, Gazeau P, Hillion S, Da\u00efen CI, Cornec DYK. Could Lymphocyte Profiling be Useful to Diagnose Systemic Autoimmune Diseases? Clin Rev Allergy Immunol. 2017;53(2):219\u201336. https:\/\/doi.org\/10.1007\/s12016-017-8608-5.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"2","key":"1423_CR29","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/cei.12795","volume":"185","author":"K Thorarinsdottir","year":"2016","unstructured":"Thorarinsdottir K, Camponeschi A, Cavallini N, et al. CD21(-\/low) B cells in human blood are memory cells. Clin Exp Immunol. 2016;185(2):252\u201362. https:\/\/doi.org\/10.1111\/cei.12795.","journal-title":"Clin Exp Immunol"},{"key":"1423_CR30","doi-asserted-by":"publisher","first-page":"103409","DOI":"10.1016\/j.ebiom.2021.103409","volume":"68","author":"J Zhang","year":"2021","unstructured":"Zhang J, He T, Xue L, Guo H. Senescent T cells: a potential biomarker and target for cancer therapy. EBioMedicine. 2021;68:103409. https:\/\/doi.org\/10.1016\/j.ebiom.2021.103409.","journal-title":"EBioMedicine"},{"issue":"1","key":"1423_CR31","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/ni.2771","volume":"15","author":"CL Lucas","year":"2014","unstructured":"Lucas CL, Kuehn HS, Zhao F, et al. Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110\u03b4 result in T cell senescence and human immunodeficiency. Nat Immunol. 2014;15(1):88\u201397. https:\/\/doi.org\/10.1038\/ni.2771.","journal-title":"Nat Immunol"},{"issue":"11","key":"1423_CR32","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/nri.2016.93","volume":"16","author":"CL Lucas","year":"2016","unstructured":"Lucas CL, Chandra A, Nejentsev S, Condliffe AM, Okkenhaug K. PI3K\u03b4 and primary immunodeficiencies. Nat Rev Immunol. 2016;16(11):702\u201314. https:\/\/doi.org\/10.1038\/nri.2016.93.","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"1423_CR33","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1007\/s10875-022-01210-y","volume":"42","author":"YC Chen","year":"2022","unstructured":"Chen YC, Weng SW, Ding JY, et al. Clinicopathological Manifestations and Immune Phenotypes in Adult-Onset Immunodeficiency with Anti-interferon-\u03b3 Autoantibodies. J Clin Immunol. 2022;42(3):672\u201383. https:\/\/doi.org\/10.1007\/s10875-022-01210-y.","journal-title":"J Clin Immunol"},{"issue":"12","key":"1423_CR34","doi-asserted-by":"publisher","first-page":"1684.e1","DOI":"10.1016\/j.cmi.2020.02.030","volume":"26","author":"UI Wu","year":"2020","unstructured":"Wu UI, Wang JT, Sheng WH, et al. Incorrect diagnoses in patients with neutralizing anti-interferon-gamma-autoantibodies. Clin Microbiol Infect. 2020;26(12):1684.e1-1684.e6. https:\/\/doi.org\/10.1016\/j.cmi.2020.02.030.","journal-title":"Clin Microbiol Infect"},{"issue":"17","key":"1423_CR35","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.1182\/blood-2011-12-395707","volume":"119","author":"SK Browne","year":"2012","unstructured":"Browne SK, Zaman R, Sampaio EP, et al. Anti-CD20 (rituximab) therapy for anti-IFN-\u03b3 autoantibody-associated nontuberculous mycobacterial infection. Blood. 2012;119(17):3933\u20139. https:\/\/doi.org\/10.1182\/blood-2011-12-395707.","journal-title":"Blood"},{"issue":"2","key":"1423_CR36","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.cmi.2017.06.029","volume":"24","author":"UI Wu","year":"2018","unstructured":"Wu UI, Chuang YC, Sheng WH, et al. Use of QuantiFERON-TB Gold In-tube assay in screening for neutralizing anti-interferon-\u03b3 autoantibodies in patients with disseminated nontuberculous mycobacterial infection. Clin Microbiol Infect. 2018;24(2):159\u201365. https:\/\/doi.org\/10.1016\/j.cmi.2017.06.029.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"1423_CR37","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/cid\/ciz786","volume":"71","author":"GH Hong","year":"2020","unstructured":"Hong GH, Ortega-Villa AM, Hunsberger S, et al. Natural History and Evolution of Anti-Interferon-\u03b3 Autoantibody-Associated Immunodeficiency Syndrome in Thailand and the United States. Clin Infect Dis. 2020;71(1):53\u201362. https:\/\/doi.org\/10.1093\/cid\/ciz786.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"1423_CR38","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1093\/cid\/ciaa1086","volume":"72","author":"S Ochoa","year":"2021","unstructured":"Ochoa S, Ding L, Kreuzburg S, Treat J, Holland SM, Zerbe CS. Daratumumab (Anti-CD38) for Treatment of Disseminated Nontuberculous Mycobacteria in a Patient With Anti-Interferon-\u03b3 Autoantibodies. Clin Infect Dis. 2021;72(12):2206\u20138. https:\/\/doi.org\/10.1093\/cid\/ciaa1086.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"1423_CR39","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.jaci.2016.06.021","volume":"139","author":"TI Coulter","year":"2017","unstructured":"Coulter TI, Chandra A, Bacon CM, et al. Clinical spectrum and features of activated phosphoinositide 3-kinase \u03b4 syndrome: A large patient cohort study. J Allergy Clin Immunol. 2017;139(2):597-606.e4. https:\/\/doi.org\/10.1016\/j.jaci.2016.06.021.","journal-title":"J Allergy Clin Immunol"},{"key":"1423_CR40","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3389\/fimmu.2018.00369","volume":"9","author":"D Michalovich","year":"2018","unstructured":"Michalovich D, Nejentsev S. Activated PI3 Kinase Delta Syndrome: From Genetics to Therapy. Front Immunol. 2018;9:369. https:\/\/doi.org\/10.3389\/fimmu.2018.00369.","journal-title":"Front Immunol"},{"issue":"3","key":"1423_CR41","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.jaci.2015.09.018","volume":"137","author":"CL Ku","year":"2016","unstructured":"Ku CL, Lin CH, Chang SW, et al. Anti-IFN-\u03b3 autoantibodies are strongly associated with HLA-DR*15:02\/16:02 and HLA-DQ*05:01\/05:02 across Southeast Asia. J Allergy Clin Immunol. 2016;137(3):945-8.e8. https:\/\/doi.org\/10.1016\/j.jaci.2015.09.018.","journal-title":"J Allergy Clin Immunol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-022-01423-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-022-01423-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-022-01423-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T05:26:03Z","timestamp":1681709163000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-022-01423-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,10]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["1423"],"URL":"https:\/\/doi.org\/10.1007\/s10875-022-01423-1","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,10]]},"assertion":[{"value":"11 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All human samples were obtained under protocols approved by the Institutional Review Board at Chang Gung Memorial Hospital (protocol 202001665A3, 202002403A3, and 201902037A3) and met the Institutional Review Board standards for ethical conduct of research with human subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Written informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The authors affirm that human research participants provided informed consent for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}